3 Sources
[1]
These chip stocks are surging due to sky-high CPU demand. UBS sees more gains ahead
Advanced Micro Devices and Arm Holdings are poised to outperform as artificial intelligence providers increasingly embrace central processing units (CPUs) and other specialized hardware to power new AI agents, according to UBS. The Swiss-based investment bank has a buy rating on both chipmakers,
[2]
UBS flags these 2 stocks as key beneficiaries of standalone CPU By Investing.com
Investing.com -- UBS raised price targets on two chip stocks in a note on Wednesday, identifying both as key beneficiaries of accelerating demand for standalone CPU deployments in agentic AI infrastructure, while pushing back against what it sees as overly aggressive market size
[3]
UBS raises Arm Holdings stock price target to $470 on AI chip outlook By Investing.com
Investing.com - UBS raised its price target on Arm Holdings (NASDAQ:ARM) to $470 from $260 while maintaining a Buy rating on the stock. The stock currently trades at $366.39, down 12.5% over the past week, though it has surged 235% year-to-date with a market capitalization of $391 billion. The
Share
Copy Link
UBS has significantly raised its price targets for AMD and Arm Holdings, citing accelerating demand for CPUs in agentic AI infrastructure. AMD's target jumped to $670 from $470, while Arm's climbed to $455-$470, reflecting the chipmakers' strategic positioning as AI providers shift toward standalone CPU deployments alongside traditional GPUs.
UBS has dramatically increased its outlook on two major chipmakers, raising its price target on AMD to $670 from $470 and Arm Holdings to between $455 and $470 from $260, signaling strong confidence in both companies as key beneficiaries of the evolving AI chip market
1
2
. The Swiss investment bank maintained its buy rating on both stocks, with analyst Timothy Arcuri pointing to accelerating traction in standalone CPU deployments as the primary driver behind the upgrades1
. The revised targets imply upside potential of approximately 28-29% from recent closing prices, reflecting Wall Street's growing recognition that AI-driven workloads extend far beyond graphics processing units.The surge in CPU demand stems directly from the emergence of agentic AI systems—autonomous platforms designed to act independently without constant human intervention. This architectural evolution has created an unexpected windfall for AMD and Arm, with both stocks soaring over 150% in just three months
1
. UBS now projects a 60/40 split between x86 and Arm architectures in the standalone segment, a significant shift that reflects how hyperscaler needs are reshaping chip design priorities2
. For AMD, which both designs and manufactures CPUs, this translates to projected server revenues of $23 billion in 2027, $29 billion in 2028, and potentially $50 billion by 20302
.AMD holds distinct advantages in standalone agentic AI racks, which tend to be more core and throughput-driven compared to traditional AI infrastructure. Arcuri noted that AMD benefits from "its advantage in core count, multithreading, and x86 [processor's] historically strong software ecosystem for traditional software workloads that are now increasingly part of the agentic AI workloads"
1
. UBS expects AMD to capture an outsized share of incremental demand, particularly given Intel's roadmap and supply challenges2
. Of 53 analysts covering AMD, 45 give it a buy or strong buy rating, underscoring broad market confidence1
.Related Stories
Arm Holdings, which came public in September 2023, brings a different competitive edge centered on latency and efficiency—qualities that align well with hyperscaler needs
1
. UBS maintains that Arm architectures will represent approximately 70% share of a roughly 20 million unit head-node market by 20302
3
. The firm raised its estimate for Arm's internal CPU revenue to approximately $14 billion in 2030, reflecting about 8% share of UBS's $170 billion total addressable market estimate2
. Arm has secured major hyperscaler customers including Meta, OpenAI, and ByteDance3
.While investor enthusiasm has pushed some total addressable market estimates toward $300 billion by 2030, UBS takes a more measured view. Arcuri cautioned that DRAM supply constraints will likely prevent such aggressive outcomes, suggesting that "DRAM will remain too constrained to enable a TAM that large by 2030"
2
. Current limitations in core count and throughput will also restrict use of Arm's first-generation internal product for standalone AI racks, where workloads need to scale across as many cores on a single machine as possible3
. However, Arm's roadmap of 200 to 500 cores could expand into broader use cases over time, though this likely requires second or third generation products3
. Arm CEO Rene Haas has emphasized the widespread integration of CPUs across applications, describing them as integral to the application space3
. With 19 analysts revising earnings upwards and more than half of the 40 analysts covering Arm issuing buy ratings, the market appears aligned with UBS's optimistic stance on both chipmakers' positioning in standalone CPU deployments1
3
.Summarized by
Navi
25 Nov 2024•Business and Economy

20 Jul 2024

24 Mar 2026•Technology

1
Technology

2
Technology

3
Science and Research
